PAR Change in substantial holding 15/11/17 download Created with Sketch. 149.3KB Share PAR Change of Director's Interest Notice 15/11/17 download Created with Sketch. 234.46KB Share PAR Cleansing Notice - Section 708A 15/11/17 download Created with Sketch. 325.72KB Share PAR Paradigms ACL Phase 2 Clinical Trial Success 14/11/17 PRICE SENSITIVE download Created with Sketch. 264.23KB Share PAR Appendix 3B 13/11/17 download Created with Sketch. 563.02KB Share PAR Results of Meeting 10/11/17 download Created with Sketch. 281.87KB Share PAR CEO Update 10/11/17 download Created with Sketch. 887.77KB Share PAR PAR Successfully Completes A$5.75m Placement 06/11/17 PRICE SENSITIVE download Created with Sketch. 398.45KB Share PAR Trading Halt 02/11/17 PRICE SENSITIVE download Created with Sketch. 617.85KB Share PAR PAR Updated Corporate Presentation 02/11/17 download Created with Sketch. 1.17MB Share PAR Appendix 4C - quarterly 31/10/17 PRICE SENSITIVE download Created with Sketch. 447.58KB Share PAR First Participant Dosed in PARs Phase 2b OA Clinical Trial 30/10/17 PRICE SENSITIVE download Created with Sketch. 383.16KB Share PAR Response to ASX Query 11/10/17 PRICE SENSITIVE download Created with Sketch. 712.77KB Share PAR Notice of Annual General Meeting/Proxy Form 10/10/17 download Created with Sketch. 746.15KB Share PAR PAR REPORTS PAIN REDUCTION IN 83% OF OSTEOARTHRITIS PATIENTS 10/10/17 PRICE SENSITIVE download Created with Sketch. 110.47KB Share PAR Appendix 3B 28/09/17 download Created with Sketch. 563.67KB Share PAR PARs Osteoarthritis Phase 2 Receives Ethics Approval 19/09/17 PRICE SENSITIVE download Created with Sketch. 125.36KB Share PAR Paradigm Phase 2 Ross River Virus Clinical Trial Update 14/09/17 PRICE SENSITIVE download Created with Sketch. 101.91KB Share PAR A PARADIGM SHIFT IN TREATING OSTEOARTHRITIS PAIN 11/09/17 PRICE SENSITIVE download Created with Sketch. 823.68KB Share PAR Appendix 4G 29/08/17 download Created with Sketch. 260.04KB Share PAR Appendix 4E and 2017 Annual Report 29/08/17 PRICE SENSITIVE download Created with Sketch. 1.02MB Share PAR Appendix 3B 21/08/17 download Created with Sketch. 556.08KB Share PAR Paradigm (PAR) - First Ross River Trial Participant Treated 09/08/17 PRICE SENSITIVE download Created with Sketch. 256.04KB Share PAR Shares released from escrow 03/08/17 download Created with Sketch. 142.07KB Share PAR Appendix 4C - quarterly 28/07/17 PRICE SENSITIVE download Created with Sketch. 417.67KB Share PAR Paradigm To Commence Phase 2 Ross River Virus Clinical Trial 10/07/17 PRICE SENSITIVE download Created with Sketch. 92.1KB Share PAR Appendix 3B 04/07/17 download Created with Sketch. 558.92KB Share PAR Change in substantial holding 28/06/17 download Created with Sketch. 40.18KB Share PAR Change of Director's Interest Notice 26/06/17 download Created with Sketch. 234.42KB Share PAR Paradigm Enters Heart Failure Market 20/06/17 PRICE SENSITIVE download Created with Sketch. 601.42KB Share PAR Q and A on Hay Fever Program 19/06/17 download Created with Sketch. 210.89KB Share PAR Hay Fever Trial Update 16/06/17 PRICE SENSITIVE download Created with Sketch. 329.25KB Share PAR Trading Halt 15/06/17 PRICE SENSITIVE download Created with Sketch. 569.93KB Share PAR Paradigm Receives Ethics Approval for Ross River Trial 22/05/17 PRICE SENSITIVE download Created with Sketch. 254.61KB Share PAR Paradigms preclinical hay fever trial published 16/05/17 PRICE SENSITIVE download Created with Sketch. 330.2KB Share PAR Paradigm Non-Deal Roadshow Presentation 15/05/17 download Created with Sketch. 1.95MB Share PAR Paradigm Government grant for Ross River virus research 11/05/17 PRICE SENSITIVE download Created with Sketch. 250KB Share PAR Paradigm March Quarter Update & Appendix 4C 28/04/17 PRICE SENSITIVE download Created with Sketch. 134.83KB Share PAR Final participant treated in Phase 2 hay fever trial 23/03/17 PRICE SENSITIVE download Created with Sketch. 250.37KB Share PAR Paradigm receives $1.34 million R&D tax incentive rebate 22/03/17 PRICE SENSITIVE download Created with Sketch. 197.94KB Share PAR Paradigm Presents to Asian Investors 21/03/17 download Created with Sketch. 198.65KB Share PAR Paradigm Update Ross River Virus Clinical Trial 07/03/17 PRICE SENSITIVE download Created with Sketch. 51.63KB Share PAR Broker Research Report for Paradigm Biopharma 02/03/17 download Created with Sketch. 241.82KB Share PAR Half Year Accounts 24/02/17 PRICE SENSITIVE download Created with Sketch. 680.61KB Share PAR Appendix 3B 07/02/17 download Created with Sketch. 663.1KB Share PAR Quarterly Cashflow Report 31/01/17 PRICE SENSITIVE download Created with Sketch. 148.35KB Share PAR Recruitment complete in Paradigms hay fever clinical trial 25/01/17 PRICE SENSITIVE download Created with Sketch. 263.49KB Share PAR Shares released from escrow 20/01/17 download Created with Sketch. 198.93KB Share PAR Appendix 3B 19/01/17 download Created with Sketch. 665.57KB Share PAR Broker Initiated Coverage 16/12/16 download Created with Sketch. 346.43KB Share PAR Change of Director's Interest Notice 15/12/16 download Created with Sketch. 227.69KB Share PAR Change of Director's Interest Notice 09/12/16 download Created with Sketch. 226.94KB Share PAR Change of Director's Interest Notice 09/12/16 download Created with Sketch. 227.08KB Share PAR Change in substantial holding 09/12/16 download Created with Sketch. 147.39KB Share PAR Change of Director's Interest Notice 09/12/16 download Created with Sketch. 255.7KB Share PAR Appendix 3B 09/12/16 download Created with Sketch. 662.27KB Share PAR Closure of SPP 02/12/16 download Created with Sketch. 342.22KB Share PAR Results of Annual General Meeting 30/11/16 download Created with Sketch. 273.28KB Share PAR Managing Director's Presentation to AGM 30/11/16 download Created with Sketch. 1.08MB Share PAR Paradigm's hay fever clinical trial cleared to commence 22/11/16 PRICE SENSITIVE download Created with Sketch. 266.45KB Share PAR PAR Share Purchase Plan 2016 - Extension 17/11/16 download Created with Sketch. 94.16KB Share PAR Cleansing Notice - Section 708A-PAR.AX 28/10/16 download Created with Sketch. 491.73KB Share PAR Appendix 4C - September 2016 quarter-PAR.AX 28/10/16 PRICE SENSITIVE download Created with Sketch. 428.5KB Share PAR Appendix 3B-PAR.AX 28/10/16 download Created with Sketch. 631.76KB Share PAR Notice of Extraordinary General Meeting/Proxy Form-PAR.AX 28/10/16 download Created with Sketch. 799.75KB Share PAR PAR Share Purchase Plan 2016-PAR.AX 21/10/16 download Created with Sketch. 613.13KB Share PAR Paradigms Placement heavily oversubscribed-PAR.AX 18/10/16 PRICE SENSITIVE download Created with Sketch. 312.64KB Share PAR Trading Halt-PAR.AX 14/10/16 PRICE SENSITIVE download Created with Sketch. 307.6KB Share PAR Paradigm Biopharmaceuticals updated corporate presentati-PAR.AX 12/10/16 download Created with Sketch. 1.27MB Share PAR Preclinical study underpins efficacy of Paradigm's RhinosulR-PAR.AX 16/09/16 PRICE SENSITIVE download Created with Sketch. 276.14KB Share PAR Change of Director's Interest Notice-PAR.AX 13/09/16 download Created with Sketch. 217.66KB Share PAR Paradigm PPS a potential in the treatment of viral arthritis-PAR.AX 07/09/16 PRICE SENSITIVE download Created with Sketch. 422.46KB Share PAR Appendix 4G-PAR.AX 31/08/16 download Created with Sketch. 263.06KB Share PAR Full Year Statutory Accounts-PAR.AX 31/08/16 download Created with Sketch. 1.02MB Share PAR Preliminary Final Report-PAR.AX 31/08/16 PRICE SENSITIVE download Created with Sketch. 40.13KB Share PAR Paradigm PPS nasal spray to treat Allergic Rhinitis-PAR.AX 19/08/16 PRICE SENSITIVE download Created with Sketch. 141.09KB Share PAR Appendix 3B-PAR.AX 12/08/16 download Created with Sketch. 62.84KB Share PAR Appendix 4C - quarterly-PAR.AX 28/07/16 PRICE SENSITIVE download Created with Sketch. 238.29KB Share PAR Shares released from escrow-PAR.AX 21/07/16 download Created with Sketch. 221.9KB Share PAR Investor Roadshow Presentation-PAR.AX 20/06/16 download Created with Sketch. 1.29MB Share PAR Baker Young Stockbrokers Initiates Coverage on Paradigm-PAR.AX 09/06/16 download Created with Sketch. 300.52KB Share PAR Shareholders Update-PAR.AX 09/06/16 PRICE SENSITIVE download Created with Sketch. 349.85KB Share PAR Investor Update Hayfever Allergic Rhinitis-PAR.AX 25/05/16 download Created with Sketch. 401.11KB Share PAR Appendix 3B-PAR.AX 09/05/16 download Created with Sketch. 76.36KB Share PAR Shares released from escrow-PAR.AX 21/04/16 download Created with Sketch. 140.85KB Share PAR Appendix 4C - quarterly-PAR.AX 14/04/16 PRICE SENSITIVE download Created with Sketch. 238.1KB Share PAR Paradigms Updated Investor Presentation 16/03/16 download Created with Sketch. 1.39MB Share PAR Change of Director's Interest Notice 15/03/16 download Created with Sketch. 224.51KB Share PAR Change in substantial holding 15/03/16 download Created with Sketch. 38.4KB Share PAR Paradigm initiates second clinical trial site 02/03/16 PRICE SENSITIVE download Created with Sketch. 46.51KB Share PAR Half Yearly Report and Accounts 25/02/16 PRICE SENSITIVE download Created with Sketch. 268.1KB Share PAR First Participant treated in Paradigms Clinical Trial 25/02/16 PRICE SENSITIVE download Created with Sketch. 52.85KB Share PAR Paradigm starts Clinical Trial 23/02/16 PRICE SENSITIVE download Created with Sketch. 55.64KB Share PAR Appendix 4C - quarterly 27/01/16 PRICE SENSITIVE download Created with Sketch. 237.91KB Share PAR European Patent Office Grants PAR Key Respiratory Patent 15/12/15 PRICE SENSITIVE download Created with Sketch. 201.87KB Share PAR Appendix 3Y 14/12/15 download Created with Sketch. 224.11KB Share PAR Elite Athlete successfully treated with Paradigm's Zilosul 03/12/15 PRICE SENSITIVE download Created with Sketch. 302.26KB Share PAR Paradigm Biopharmaceuticals Receives Ethics Approval 23/11/15 PRICE SENSITIVE download Created with Sketch. 382.81KB Share PAR Appendix 3B - Release from escrow 10/11/15 download Created with Sketch. 561.01KB Share PAR Results of Meeting 30/10/15 download Created with Sketch. 46KB Share
(20min delay)
